Teva pharmaceutical industries limited TEVA.US 總覽分析
)TEVA 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分中等，已經有部位可以持續持有，若想建立新部位可以等待價值評分轉變為4分以上、股利提升為2分以上
TEVA 近期報酬表現
2.67%
Teva pharmaceutical industries limited
1.31%
同產業平均
0.58%
S&P500
與 TEVA 同產業的標的表現
- BIOA Bioage labs inc價值 -趨勢 3 分波段 4 分籌碼 2 分股利 1 分查看更多
TEVA 公司資訊
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.